A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

557

Participants

Timeline

Start Date

September 20, 2013

Primary Completion Date

November 4, 2014

Study Completion Date

November 4, 2014

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin degludec/liraglutide

Insulin degludec/liraglutide is injected subcutaneously s.c. (under the skin) once daily (OD). Dose individually adjusted. Subjects should continue their pre-trial treatment with metformin.

DRUG

insulin glargine

Insulin glargine is injected subcutaneously s.c. (under the skin) once daily (OD). Dose individually adjusted. Subjects should continue their pre-trial treatment with metformin.

Trial Locations (91)

1449

Novo Nordisk Investigational Site, Alberton

1685

Novo Nordisk Investigational Site, Midrand

2148

Novo Nordisk Investigational Site, Blacktown

2500

Novo Nordisk Investigational Site, Wollongong

3135

Novo Nordisk Investigational Site, East Ringwood

3300

Novo Nordisk Investigational Site, Eger

3400

Novo Nordisk Investigational Site, Corrientes

3526

Novo Nordisk Investigational Site, Miskolc

4029

Novo Nordisk Investigational Site, Herston

4226

Novo Nordisk Investigational Site, Robina

4305

Novo Nordisk Investigational Site, Ipswich

4400

Novo Nordisk Investigational Site, Salta

4450

Novo Nordisk Investigational Site, Durban

5700

Novo Nordisk Investigational Site, Gyula

9024

Novo Nordisk Investigational Site, Győr

16602

Novo Nordisk Investigational Site, Altoona

18012

Novo Nordisk Investigational Site, Granada

19140

Novo Nordisk Investigational Site, Philadelphia

28401

Novo Nordisk Investigational Site, Wilmington

33027

Novo Nordisk Investigational Site, Pembroke Pines

33165

Novo Nordisk Investigational Site, Miami

33316

Novo Nordisk Investigational Site, Fort Lauderdale

33603

Novo Nordisk Investigational Site, Tampa

34000

Novo Nordisk Investigational Site, Durango

34201

Novo Nordisk Investigational Site, Bradenton

37660

Novo Nordisk Investigational Site, Kingsport

38017

Novo Nordisk Investigational Site, Collierville

40213

Novo Nordisk Investigational Site, Louisville

40503

Novo Nordisk Investigational Site, Lexington

41003

Novo Nordisk Investigational Site, Seville

41010

Novo Nordisk Investigational Site, Seville

42084

Novo Nordisk Investigational Site, Pachuca

45005

Novo Nordisk Investigational Site, Franklin

45500

Novo Nordisk Investigational Site, Ioannina

46026

Novo Nordisk Investigational Site, Valencia

46360

Novo Nordisk Investigational Site, Michigan City

47725

Novo Nordisk Investigational Site, Evansville

60031

Novo Nordisk Investigational Site, Gurnee

62250

Novo Nordisk Investigational Site, Cuernavaca

63303

Novo Nordisk Investigational Site, Saint Charles

64460

Novo Nordisk Investigational Site, Monterrey

73103

Novo Nordisk Investigational Site, Oklahoma City

73104

Novo Nordisk Investigational Site, Oklahoma City

78224

Novo Nordisk Investigational Site, San Antonio

80906

Novo Nordisk Investigational Site, Colorado Springs

80909

Novo Nordisk Investigational Site, Colorado Springs

90720

Novo Nordisk Investigational Site, Los Alamitos

91701

Novo Nordisk Investigational Site, Trnava

92111

Novo Nordisk Investigational Site, San Diego

92262

Novo Nordisk Investigational Site, Palm Springs

93201

Novo Nordisk Investigational Site, Veľký Meder

93401

Novo Nordisk Investigational Site, Levice

93720

Novo Nordisk Investigational Site, Fresno

97101

Novo Nordisk Investigational Site, Prievidza

98057

Novo Nordisk Investigational Site, Renton

99218

Novo Nordisk Investigational Site, Spokane

117036

Novo Nordisk Investigational Site, Moscow

123448

Novo Nordisk Investigational Site, Moscow

188643

Novo Nordisk Investigational Site, Vsevolozhsk

194354

Novo Nordisk Investigational Site, Saint Petersburg

194358

Novo Nordisk Investigational Site, Saint Petersburg

199034

Novo Nordisk Investigational Site, Saint Petersburg

400131

Novo Nordisk Investigational Site, Volgograd

420073

Novo Nordisk Investigational Site, Kazan'

610014

Novo Nordisk Investigational Site, Kirov

630117

Novo Nordisk Investigational Site, Novosibirsk

634041

Novo Nordisk Investigational Site, Tomsk

634050

Novo Nordisk Investigational Site, Tomsk

70461-4231

Novo Nordisk Investigational Site, Slidell

75390-9302

Novo Nordisk Investigational Site, Dallas

84088-8871

Novo Nordisk Investigational Site, West Jordan

B1704ETD

Novo Nordisk Investigational Site, Buenos Aires

C1056ABJ

Novo Nordisk Investigational Site, Capital Federal

B2800DGH

Novo Nordisk Investigational Site, Zárate

GR-11527

Novo Nordisk Investigational Site, Athens

GR-14233

Novo Nordisk Investigational Site, Athens

GR-41110

Novo Nordisk Investigational Site, Larissa

GR-54642

Novo Nordisk Investigational Site, Thessaloniki

GR-56403

Novo Nordisk Investigational Site, Thessaloniki

GR-57001

Novo Nordisk Investigational Site, Thessaloniki

H-1134

Novo Nordisk Investigational Site, Budapest

03300

Novo Nordisk Investigational Site, Mexico City

08501

Novo Nordisk Investigational Site, Bardejov

02601

Novo Nordisk Investigational Site, Dolný Kubín

040 11

Novo Nordisk Investigational Site, Košice

04001

Novo Nordisk Investigational Site, Košice

Novo Nordisk Investigational Site, Almería

03491

Novo Nordisk Investigational Site, Ľubochňa

05801

Novo Nordisk Investigational Site, Poprad

01701

Novo Nordisk Investigational Site, Považská Bystrica

07014

Novo Nordisk Investigational Site, Palma de Mallorca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01952145 - A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter